Cargando…

Neutralizing Antibodies against Lassa Virus Lineage I

Lassa virus (LASV) is the causative agent of the deadly Lassa fever (LF). Seven distinct LASV lineages circulate through western Africa, among which lineage I (LI), the first to be identified, is particularly resistant to antibody neutralization. Lineage I LASV evades neutralization by half of known...

Descripción completa

Detalles Bibliográficos
Autores principales: Buck, Tierra K., Enriquez, Adrian S., Schendel, Sharon L., Zandonatti, Michelle A., Harkins, Stephanie S., Li, Haoyang, Moon-Walker, Alex, Robinson, James E., Branco, Luis M., Garry, Robert F., Saphire, Erica Ollmann, Hastie, Kathryn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426445/
https://www.ncbi.nlm.nih.gov/pubmed/35730904
http://dx.doi.org/10.1128/mbio.01278-22
_version_ 1784778680966316032
author Buck, Tierra K.
Enriquez, Adrian S.
Schendel, Sharon L.
Zandonatti, Michelle A.
Harkins, Stephanie S.
Li, Haoyang
Moon-Walker, Alex
Robinson, James E.
Branco, Luis M.
Garry, Robert F.
Saphire, Erica Ollmann
Hastie, Kathryn M.
author_facet Buck, Tierra K.
Enriquez, Adrian S.
Schendel, Sharon L.
Zandonatti, Michelle A.
Harkins, Stephanie S.
Li, Haoyang
Moon-Walker, Alex
Robinson, James E.
Branco, Luis M.
Garry, Robert F.
Saphire, Erica Ollmann
Hastie, Kathryn M.
author_sort Buck, Tierra K.
collection PubMed
description Lassa virus (LASV) is the causative agent of the deadly Lassa fever (LF). Seven distinct LASV lineages circulate through western Africa, among which lineage I (LI), the first to be identified, is particularly resistant to antibody neutralization. Lineage I LASV evades neutralization by half of known antibodies in the GPC-A antibody competition group and all but one of the antibodies in the GPC-B competition group. Here, we solve two cryo-electron microscopy (cryo-EM) structures of LI GP in complex with a GPC-A and a GPC-B antibody. We used complementary structural and biochemical techniques to identify single-amino-acid substitutions in LI that are responsible for immune evasion by each antibody group. Further, we show that LI infection is more dependent on the endosomal receptor lysosome-associated membrane protein 1 (LAMP1) for viral entry relative to LIV. In the absence of LAMP1, LI requires a more acidic fusion pH to initiate membrane fusion with the host cell relative to LIV.
format Online
Article
Text
id pubmed-9426445
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-94264452022-08-31 Neutralizing Antibodies against Lassa Virus Lineage I Buck, Tierra K. Enriquez, Adrian S. Schendel, Sharon L. Zandonatti, Michelle A. Harkins, Stephanie S. Li, Haoyang Moon-Walker, Alex Robinson, James E. Branco, Luis M. Garry, Robert F. Saphire, Erica Ollmann Hastie, Kathryn M. mBio Research Article Lassa virus (LASV) is the causative agent of the deadly Lassa fever (LF). Seven distinct LASV lineages circulate through western Africa, among which lineage I (LI), the first to be identified, is particularly resistant to antibody neutralization. Lineage I LASV evades neutralization by half of known antibodies in the GPC-A antibody competition group and all but one of the antibodies in the GPC-B competition group. Here, we solve two cryo-electron microscopy (cryo-EM) structures of LI GP in complex with a GPC-A and a GPC-B antibody. We used complementary structural and biochemical techniques to identify single-amino-acid substitutions in LI that are responsible for immune evasion by each antibody group. Further, we show that LI infection is more dependent on the endosomal receptor lysosome-associated membrane protein 1 (LAMP1) for viral entry relative to LIV. In the absence of LAMP1, LI requires a more acidic fusion pH to initiate membrane fusion with the host cell relative to LIV. American Society for Microbiology 2022-06-22 /pmc/articles/PMC9426445/ /pubmed/35730904 http://dx.doi.org/10.1128/mbio.01278-22 Text en Copyright © 2022 Buck et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Buck, Tierra K.
Enriquez, Adrian S.
Schendel, Sharon L.
Zandonatti, Michelle A.
Harkins, Stephanie S.
Li, Haoyang
Moon-Walker, Alex
Robinson, James E.
Branco, Luis M.
Garry, Robert F.
Saphire, Erica Ollmann
Hastie, Kathryn M.
Neutralizing Antibodies against Lassa Virus Lineage I
title Neutralizing Antibodies against Lassa Virus Lineage I
title_full Neutralizing Antibodies against Lassa Virus Lineage I
title_fullStr Neutralizing Antibodies against Lassa Virus Lineage I
title_full_unstemmed Neutralizing Antibodies against Lassa Virus Lineage I
title_short Neutralizing Antibodies against Lassa Virus Lineage I
title_sort neutralizing antibodies against lassa virus lineage i
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426445/
https://www.ncbi.nlm.nih.gov/pubmed/35730904
http://dx.doi.org/10.1128/mbio.01278-22
work_keys_str_mv AT bucktierrak neutralizingantibodiesagainstlassaviruslineagei
AT enriquezadrians neutralizingantibodiesagainstlassaviruslineagei
AT schendelsharonl neutralizingantibodiesagainstlassaviruslineagei
AT zandonattimichellea neutralizingantibodiesagainstlassaviruslineagei
AT harkinsstephanies neutralizingantibodiesagainstlassaviruslineagei
AT lihaoyang neutralizingantibodiesagainstlassaviruslineagei
AT moonwalkeralex neutralizingantibodiesagainstlassaviruslineagei
AT robinsonjamese neutralizingantibodiesagainstlassaviruslineagei
AT brancoluism neutralizingantibodiesagainstlassaviruslineagei
AT garryrobertf neutralizingantibodiesagainstlassaviruslineagei
AT saphireericaollmann neutralizingantibodiesagainstlassaviruslineagei
AT hastiekathrynm neutralizingantibodiesagainstlassaviruslineagei